Outbound Investment

• Lin-Gang Special Area of the China (Shanghai) Pilot Free Trade Zone, General Data List for the Cross-Border Transfer of Data in Biomedical Sector Scenarios (Trial Implementation)

  中国（上海）自由贸易试验区临港新片区生物医药领域数据跨境场景化一般数据清单 （试行）

  Shanghai FTZ elaborates on the general data of the biomedical sector

  July 02, 2024

• Individual Risk From Potential Criminal Investigation in the United States

  Karen R King, partner at Morvillo Abramowitz Grand Iason & Anello P.C., and Jianwei (Jerry) Fang, partner at Zhong Lun Law Firm, describe how U.S. jurisdiction can reach Chinese nationals, and how to mitigate any personal risk

  June 28, 2024

  

• In the News: Reverse CFIUS Draft; Shein UK Listing; and AI-Related Venture Capital

  The U.S. publishes details on "Reverse CFIUS;" Shein's London listing might face obstacles; and two of the top 10 VC deals globally involve China, with much of the funding coming from Chinese state-backed investors.

  June 27, 2024

  

• In the News: Adidas' Alleged China Bribery; Alternative Chinese Fund Raising from US Convertibles; and EU EV Tariffs

  Alleged receiving of kickbacks by senior executives in China could subject Adidas to Chinese, as well as German and U.S. investigations; U.S. convertible bond market is used to raise funds by Chinese big tech amid IPO restrictions; and EU tariffs may lead to localization of Chinese EV production.

  June 21, 2024

  

• The Shanghai Whitelist Pilot for Data Transfers

  Philip Qu and Qiuchen Wang from TransAsia Lawyers analyze a pioneering approach to regulating cross-border data transfers recently adopted in one of Shanghai's free trade zones

  June 12, 2024

  

• In the News: Investors Turn to Invest in China's Secondary PE Market; Mad Dash for Chinese AI Pharma IPO; and China Issues New Carbon Emissions Measures

  International investors find Chinese secondary PE market an alternative amid U.S.-China tensions; QuantumPharm is the first IPO under Hong Kong's new measure for pre-revenue specialist technology firms; and China releases new carbon measuring standards foreseeing new EU carbon tariffs.

  June 11, 2024

  

• In the News: Chinese Court Favors Apple in Antitrust Case; Temu Now Under Stricter EU Rules; and Chinese FDI Circumvents US Tariffs

  Apple wins antitrust case in China over app store fees; Temu is now subject to stricter EU online content rules; and Record Chinese investments flow into Mexico and Vietnam amid Western trade tensions.

  June 06, 2024

  

• In the News: China Biotech FDI; US Lithium Battery Factories; and Chinese Pharma in the UK

  Western companies are investing in Chinese biotech even amid continued geopolitical tension between China and the West and decreasing appetite for foreign investment in China; Two lithium battery part manufacturers, Capchem and Kedaliplan, plan to build factories in the U.S. to avoid hefty lithium battery tariffs; and Chinese pharma firm Asymchem to take over U.K. Pfizer plant.

  May 29, 2024

  

• In the News: Shanghai Whitelists Data for Cross-Border Transfer; Landmark US Anti-Dumping Case; and Chinese Aiway's SPAC Merger

  Shanghai FTZ expedites cross-border transfer of specified data; CBP investigation finds no substantial evidence of evasion by CIE; and Another Chinese EV SPAC merger is in the pipeline but EU tariffs threaten the business.

  May 23, 2024

  

• How PE Investors Can Avoid Pitfalls When Investing in PRC-Related Deals

  Charles Wu of Clyde & Co describes the current regulatory state of China's investment market, for private equity investors, including the much anticipated recent clarity provided by key regulators as well as potential pitfalls to avoid

  May 22, 2024